Inventor

XUE CHU-BIAO

US59 patents

⚠️ This page may combine multiple inventors who share the name “XUE CHU-BIAO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

XUE CHU-BIAO

INCYTE CORP

Piperidin-4-yl azetidine derivatives as JAK1 inhibitors

Piperidin-4-yl azetidine derivatives as JAK1 inhibitors

Thiazolecarboxamides and pyridinecarboxamide compounds useful as Pim kinase inhibitors

Piperidin-4-yl azetidine derivatives as JAK1 inhibitors

Piperidin-4-yl azetidine derivatives as JAK1 inhibitors

Bicyclic aromatic carboxamide compounds useful as Pim kinase inhibitors

Thiazolecarboxamides and pyridinecarboxamide compounds useful as Pim kinase inhibitors

Thiazolecarboxamides and pyridinecarboxamide compounds useful as Pim kinase inhibitors

Bicyclic aromatic carboxamide compounds useful as pim kinase inhibitors

Thiazolecarboxamides and pyridinecarboxamide compounds useful as Pim kinase inhibitors

Furo- and thieno-pyridine carboxamide compounds useful as pim kinase inhibitors

Thiazolecarboxamides and pyridinecarboxamide compounds useful as pim kinase inhibitors

Thiazolecarboxamides and pyridinecarboxamide compounds useful as PIM kinase inhibitors

Furo- and thieno-pyridine carboxamide compounds useful as pim kinase inhibitors

Purinone derivatives as HM74A agonists

3-(4-heteroarylcyclohexylamino)cyclopentanecarboxamides as modulators of chemokine receptors

3-cycloalkylaminopyrrolidine derivatives as modulators of chemokine receptors

3-aminopyrrolidine derivatives as modulators of chemokine receptors

3-aminopyrrolidine derivatives as modulators of chemokine receptors

Piperazinylpiperidine derivatives as chemokine receptor antagonists

Purinone derivatives as HM74a agonists

Thiazolecarboxamides and pyridinecarboxamide compounds useful as Pim kinase inhibitors

Purinone derivatives as HM74A agonists

3-aminocyclopentanecrboxamides as modulators of chemokine receptors

3-aminocyclopentanecarboxamides as modulators of chemokine receptors

3-aminopyrrolidine derivatives as modulators of chemokine receptors

Piperazinylpiperidine derivatives as chemokine receptor antagonists

Purinone derivatives as HM74A agonists

Purinone derivatives as HM74A agonists

BRISTOL MYERS SQUIBB PHARMA CO

Cyclic hydroxamic acids as metalloproteinase inhibitors

Cyclic hydroxamic acid as metalloproteinase inhibitors

Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE)

Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE)

Amide derivatives as inhibitors of matrix metalloproteinases, TNF-α, and aggrecanase

Cyclic β-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-α

Cyclic β-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-α

1,1-disubstituted cyclic inhibitors of matrix metalloproteases and TNF-α

1,2,-Disubstituted cyclic inhibitors of matrix metalloproteases and TNF-alpha

DU PONT MERCK PHARMA

Isoxazoline and isoxazole fibrinogen receptor antagonists

Aromatic compounds containing basic and acidic termini useful as fibrinogen receptor antagonists

Hydroxamic acid compounds as metalloprotease and TNF inhibitors

Compounds containing basic and acidic termini useful as fibrinogen receptor antagonists

DU PONT PHARM CO

Substituted aryl hydroxamic acids as metalloproteinase inhibitors

Amide derivatives as inhibitors of matrix metalloproteinases, TNF-α, and aggrecanase

Isoxazoline and isoxazole fibrogen receptor antagonists

HUANG TAISHENG

Piperidin-4-yl azetidine derivatives as JAK1 inhibitors

PFIZER

3-aminocyclopentanecarboxamides as modulators of chemokine receptors

XUE CHU-BIAO

Piperazinylpiperidine derivatives as chemokine receptor antagonists

BRISTOL MYERS SQUIBB CO

Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE)

ZHENG CHANGSHENG

Purinone derivatives as HM74A agonists